Managed Care
Overview
Crowell & Moring is nationally preeminent in providing legal services for the managed care and health insurance industry. We have worked closely with the managed care industry for many years, and bring to our services deep familiarity with the business and legal needs of our managed care clients. We represent leading managed care companies and integrated delivery systems, both for profit and not-for-profit, across the country. Our lawyers are leaders in the field of managed care law and are relied upon for their in-depth knowledge.
Our experience focuses on the litigation, transactional, and regulatory needs of health plans across the country. We have extensive experience with the California Knox-Keene Act and the insurance laws impacting plans in California and other states. We assist companies in obtaining licensure and advise them on a wide array of state and federal regulatory requirements, including change in control requirements, mandated benefits, rating requirements, marketing activities and producer arrangements, antitrust and unfair insurance trade practice laws, insurance holding company laws, financial solvency, subrogation and coordination of benefits, privacy and security breach issues, outsourcing arrangements, and relationships with providers, including prompt payment and provider risk-assumption issues.
Contacts
Insights
Client Alert | 21 min read | 12.04.25
Highlights: CMS’s Proposed Rule for Medicare Part C & D (CY 2027 NPRM)
On November 26, 2025, the Centers for Medicare & Medicaid Services (CMS) published its Proposed Rule for the Medicare Program; Contract Year 2027 Policy and Technical Changes to the Medicare Advantage Program, Medicare Prescription Drug Benefit Program, and Medicare Cost Plan Program (the “CY 2027 NPRM” or “proposed rule”) for public comment. In addition to outlining prospective policy and technical changes to Medicare Advantage (Part C), the Medicare Prescription Drug Benefit (Part D), and Medicare Cost Plan regulations, the proposals showcase the government’s plans to make comprehensive updates in response to statutory changes—notably the Inflation Reduction Act of 2022 (IRA)—as well as feedback from interested parties, and current federal deregulatory priorities.
Client Alert | 5 min read | 11.26.25
Speaking Engagement | 09.09.25
Insights
"Unpacking Republican Proposals to Roll Back Obamacare," Daily Journal
|12.12.16
CMS Proposes Significant Changes Impacting Medicare Appeals Processes
|07.18.16
American Health Lawyers Association Payers, Plans, and Managed Care Newsletter
'SGR Fix' Law Adds Program-Integrity Tools, Exempts Gainsharing From Penalties
|04.20.15
Report on Medicare Compliance
Medicaid Managed Care Final Rule: Prevention of Fraud, Waste, and Abuse
|08.04.16
Crowell & Moring's Health Law Blog
Professionals
Insights
Client Alert | 21 min read | 12.04.25
Highlights: CMS’s Proposed Rule for Medicare Part C & D (CY 2027 NPRM)
On November 26, 2025, the Centers for Medicare & Medicaid Services (CMS) published its Proposed Rule for the Medicare Program; Contract Year 2027 Policy and Technical Changes to the Medicare Advantage Program, Medicare Prescription Drug Benefit Program, and Medicare Cost Plan Program (the “CY 2027 NPRM” or “proposed rule”) for public comment. In addition to outlining prospective policy and technical changes to Medicare Advantage (Part C), the Medicare Prescription Drug Benefit (Part D), and Medicare Cost Plan regulations, the proposals showcase the government’s plans to make comprehensive updates in response to statutory changes—notably the Inflation Reduction Act of 2022 (IRA)—as well as feedback from interested parties, and current federal deregulatory priorities.
Client Alert | 5 min read | 11.26.25
Speaking Engagement | 09.09.25
